Use Able AI chat for product recommendations

Recombinant Rat Angiotensinogen/AGT protein (rFc Tag) (HPLC verified)

Species

Rat

Purity

>90 %, SDS-PAGE
>90 %, SEC-HPLC

Tag

rFc Tag

Activity

not tested

Cat no : Eg3273



Product Information

Purity >90 %, SDS-PAGE
>90 %, SEC-HPLC
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Rat Angiotensinogen protein Asp25-Val477 (Accession# P01015) with a rabbit IgG Fc tag at the C-terminus.
GeneID 24179
Accession P01015
PredictedSize 75.8 kDa
SDS-PAGE 75-90 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

Angiotensinogen (AGT) is a key component of the renin-angiotensin system (RAS), which plays a crucial role in blood pressure regulation and cardiovascular homeostasis Angiotensinogen is expressed in various tissues, including the liver, kidneys, and brain. In rats, the expression of angiotensinogen can be influenced by various factors such as stress, diet, and hormonal changes. For example, angiotensinogen expression in the brain can be affected by dehydration and salt loading, leading to changes in blood pressure and fluid balance. Transgenic rats with ubiquitous expression of angiotensinogen have been developed to study the role of the protective arm of the RAS in cardio-renal diseases.

References:

1. Ranasinghe P, Addison ML, et al. (2022) J Am Heart Assoc. 11(20):e027694. 2. Uijl E, Mirabito Colafella KM, et al. (2019) Hypertension. 73(6):1249-1257. 3. Colόn NS, Pantho AF, et al. (2022) Pregnancy Hypertens. 227:1-5. 4. Ye D, Cruz-López EO, et al.(2024) Hypertension. 81(7):1491-1499.

||
New chat

Able™

正在加载,请稍候...